• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Sol-Gel Technologies Ltd (NQ: SLGL )

    0.5647 +0.0087 (+1.56%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Sol-Gel Technologies Ltd

    < Previous 1 2 Next >
    SLGL Stock Earnings: Sol-Gel Technologies Beats EPS, Beats Revenue for Q2 2024
    SLGL stock results show that Sol-Gel Technologies beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    SLGL Stock Earnings: Sol-Gel Technologies Misses EPS, Misses Revenue for Q1 2024
    SLGL stock results show that Sol-Gel Technologies missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Sol-Gel Technologies: Q4 Earnings Insights
    Via Benzinga
    Recap: Sol-Gel Technologies Q3 Earnings
    Via Benzinga
    Expert Ratings for Sol-Gel Technologies
    Via Benzinga
    Week in Review: Takeda Options Alzheimer's Therapy From AC Immune In $2.2 Billion Deal
    In the headline deal, Takeda acquires global rights from AC Immune of Switzerland for $100 million upfront and up to $2.1B in milestones. 
    Via Talk Markets
    Stocks That Hit 52-Week Lows On Thursday
      On Thursday, 369 companies hit new 52-week lows. 
    Via Benzinga
    Sol-Gel Technologies: Q1 Earnings Insights
    Sol-Gel Technologies (NASDAQ:SLGL) reported its Q1 earnings results on Friday, May 13, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
    Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
    Via Benzinga
    Exposures Product Safety
    Stocks That Hit 52-Week Lows On Friday
      Friday's session saw 112 companies set new 52-week lows. 
    Via Benzinga
    7 Biotech Stocks That Could Be the Next Big Thing
    Although speculation might be a tough call at this juncture, these biotech stocks and their underlying science might be compelling enough. 
    Via InvestorPlace
    The Top 7 Penny Stocks to Invest in for the Long-Term
    Although penny stocks represent extremely high risks, a select few ideas could make for enticing long-term propositions. 
    Via InvestorPlace
    Stocks That Hit 52-Week Lows On Tuesday
      On Tuesday, 386 stocks made new 52-week lows. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
      Friday's session saw 169 companies set new 52-week lows. 
    Via Benzinga
    Heska To $165? Plus BTIG Cuts PT On This Stock By 67%
    BTIG cut the price target on Gain Therapeutics, Inc. (NASDAQ: GANX) from $30 to $10. BTIG analyst Thomas Shrader maintained a Buy rating on the stock. Gain Therapeutics shares rose 1.3% to close at... 
    Via Benzinga
    What Does Sunshine Biopharma's Acquisition Of Nora Pharma Mean For The Generic Prescription Drugs Market?
    The generic drug market has been growing since 1984 when the Hatch-Waxman Act encouraged manufacturing generics and developed a framework to regulate them. 
    Via Benzinga
    Why Edible Garden Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Gainers Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) shares jumped 69.6% to $15.01 after dropping 24% on Tuesday. 
    Via Benzinga
    Nasdaq Turns Higher; Applied Genetic Technologies Shares Surge
    U.S. stocks traded mostly higher midway through trading, with the Dow Jones surging more than 300 points on Monday. 
    Via Benzinga
    Why Is Allena Pharmaceuticals Jumping By 207%? 45 Stocks Moving In Wednesday's Mid-Day Session
    Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 207% to $0.3650 after the company announced it has terminated its previously announced at-the-market offering. 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2022
    Upgrades 
    Via Benzinga
    The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Commences Late-Stage Study Of Heart Failure Treatment Merck &... 
    Via Benzinga
    Why Bank Stocks Traded Sharply Higher; Here's 65 Biggest Movers From Friday
    Gainers United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Friday. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering... 
    Via Benzinga
    Sol-Gel Wins FDA Approval For Fixed-Dose Combination Of Tretinoin, Benzoyl Peroxide For Acne Vulgaris
    The FDA has approved Sol-Gel Technologies Ltd's (NASDAQ: SLGL) first proprietary drug product, Twyneo (tretinoin/benzoyl peroxide) cream, 0.1%/3%, indicated... 
    Via Benzinga
    Exposures Product Safety
    Citigroup, Bank of America And 48 Stocks Moving In Friday's Mid-Day Session
    Gainers United Maritime Corporation (NASDAQ: USEA) shares jumped 180.9% to $6.19. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on Wednesday. 
    Via Benzinga
    Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates
    Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May. ACADIA Pharmaceuticals Inc.'s (NASDAQ: ACAD) Nuplazid... 
    Via Benzinga
    Earnings Scheduled For August 4, 2021
    Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter. • Vericel (NASDAQ:VCEL) is expected to... 
    Via Benzinga
    74 Biggest Movers From Friday
    Gainers MoSys, Inc. (NASDAQ: MOSY) shares climbed 50.5% to settle at $4.35 on Friday. MoSys, last week, reported a loss for its first quarter. HyreCar Inc. (NASDAQ: HYRE) shares... 
    Via Benzinga
    77 Biggest Movers From Yesterday
    Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) shares surged 23.7% to close at $12.77. Moxian, Inc. (NASDAQ: MOXC) jumped 23.6% to close at $9.52. Repro Med Systems, Inc... 
    Via Benzinga
    52 Biggest Movers From Yesterday
    Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) gained 51.2% to close at $24.90 on Tuesday. Urban Tea, Inc. (NASDAQ: MYT) rose 38.1% to settle at $4.64. Vaxart, Inc. (... 
    Via Benzinga
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.